** Cancer and rare diseases drugmaker Springworks Therapeutics' SWTX.O shares surge, up about 30% to $52.70 in morning trade
** Reuters reports that German healthcare and technology group, Merck KGaA MRCG.DE is in advanced talks to acquire SWTX, according to people familiar with the matter
** If the talks are successful, a deal could be signed in the coming weeks, according to Reuters' sources
** Both Springworks and Merck declined to comment
** SWTX stock has risen 12% in the last 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。